Barriers and Pathways to Changing Smoking and Risky Drinking in Primary Care Patients With Chronic Conditions Who Failed to Respond to Brief Advice
Many individuals who smoke tobacco or consume alcohol at hazardous levels have chronic conditions that are caused or exacerbated by these behaviors. How might you help these patients to change?
Category
  • Medical Conditions
  • Primary Care
  • Smoking
  • Substance Use Disorders
Format
  • Journal
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Do Not Drink, Do Not Drive: Alcohol Use Disorder in the Elderly
When older patients present with cognitive decline, it is important to rule out any organic, mood-related, or substance-induced etiology, such as alcohol use disorder.
Category
  • Cognition
  • Geriatric Psychiatry
  • Primary Care
  • Substance Use Disorders
Format
  • Journal
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Improving Standards of Care in Type 2 Diabetes with Chronic Kidney Disease: Integrating the Non-Steroidal Mineralocorticoid Antagonist Class in Cardiorenal Medicine
How to screen UACR and eGFR levels, implement selective non-steroidal MRA therapies, and mitigate the risk of hyperkalemia to prevent CKD disease progression
Category
  • Renal Disease
  • Primary Care
  • Patient/Physician Communication
  • Side Effects
  • Cardiology
  • Metabolic Disorders
  • Diagnostic Tools
Format
  • Self-study / Enduring
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Translating Clinical Trial Data into Real-World Practice: Examining CKD Screening and Three Patient Case Profiles
Regular screening of UACR and adding finerenone to SGLT2 inhibitors can greatly impact T2D at risk for CKD. Join faculty as they discuss three patient cases.
Category
  • Renal Disease
  • Adherence
  • Cardiology
  • Comorbidity
  • Diagnostic Tools
  • Education
  • Medical Conditions
  • Primary Care
  • Side Effects
  • Weight
Format
  • Video
  • Self-study / Enduring
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Tweetorial: Diagnosing and Treating Alzheimer Disease During the Early Stage
Prompt treatment of early-stage Alzheimer disease (AD) can curb symptom progression. Tests for biomarkers, new symptomatic treatments and disease-modifying agents, and the addition of the preclinical stage to AD diagnostic criteria can aid in earlier disease recognition and building treatment plans.
Category
  • Alzheimer Disease
  • Dementia
  • Integrated Care
  • Neuroimaging
  • Patient/Physician Communication
  • Primary Care
Format
  • Tweetorial
  • Self-study / Enduring
Credits
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Participation
Facilitating Treatment Initiation in Early-Stage Alzheimer Disease
Many new therapies for early-stage AD have made their way onto the scene that can delay onset of the disease and/or slow down progression. Find out the how, what, when to better treat your patients with AD from specialists in the field.
Category
  • Alzheimer Disease
  • Dementia
  • Integrated Care
  • Neuroimaging
  • Patient/Physician Communication
  • Primary Care
Format
  • Video
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
Timely Diagnosis of Alzheimer Disease
Early-stage diagnosis of Alzheimer disease leads to prompt treatment initiation and better patient QoL. Learn about new guidelines and technology advances and what’s on the horizon from authorities in the field.
Category
  • Alzheimer Disease
  • Dementia
  • Neuroimaging
  • Primary Care
Format
  • Video
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation